We found that among patients with diabetes aged 66 and older, the incidence of nAMD was approximately 1 in 1,000 in those who had never used GLP-1 receptor agonists, compared to about 2 in 1,000 among those who had been exposed to these medications for at least six months, Muni said
In this episode of the Kwik Brain podcast, I sit down with Dr
Important KLOW Research Limitations The blend contains several distinct layers of scientific uncertainty
Here is the important catch
Careful dosing and monitoring are vital to avoid adverse effects like fluid retention or gastrointestinal issues
NLRP6 deficiency also disrupts goblet cell mucus secretion and the production of epithelial IL-18 and AMPs, impairing bacterial control (219, 220), and leading to AMPs imbalance, dysbiosis, and autoimmunity